BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 15961274)

  • 1. As2O3-induced c-Src/EGFR/ERK signaling is via Sp1 binding sites to stimulate p21WAF1/CIP1 expression in human epidermoid carcinoma A431 cells.
    Liu ZM; Huang HS
    Cell Signal; 2006 Feb; 18(2):244-55. PubMed ID: 15961274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opposite effect of ERK1/2 and JNK on p53-independent p21WAF1/CIP1 activation involved in the arsenic trioxide-induced human epidermoid carcinoma A431 cellular cytotoxicity.
    Huang HS; Liu ZM; Ding L; Chang WC; Hsu PY; Wang SH; Chi CC; Chuang CH
    J Biomed Sci; 2006 Jan; 13(1):113-25. PubMed ID: 16283431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory role of TGIF in the As2O3-regulated p21 WAF1/CIP1 expression.
    Liu ZM; Huang HS
    J Biomed Sci; 2008 May; 15(3):333-42. PubMed ID: 18210215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasminogen activator inhibitor type-1 gene expression and induced migration in TGF-beta1-stimulated smooth muscle cells is pp60(c-src)/MEK-dependent.
    Samarakoon R; Higgins CE; Higgins SP; Kutz SM; Higgins PJ
    J Cell Physiol; 2005 Jul; 204(1):236-46. PubMed ID: 15622520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p21WAF1 expression induced by MEK/ERK pathway activation or inhibition correlates with growth arrest, myogenic differentiation and onco-phenotype reversal in rhabdomyosarcoma cells.
    Ciccarelli C; Marampon F; Scoglio A; Mauro A; Giacinti C; De Cesaris P; Zani BM
    Mol Cancer; 2005 Dec; 4():41. PubMed ID: 16351709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidermal growth factor receptor-mediated proliferation of enterocytes requires p21waf1/cip1 expression.
    Sheng G; Bernabe KQ; Guo J; Warner BW
    Gastroenterology; 2006 Jul; 131(1):153-64. PubMed ID: 16831599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cooperation of H2O2-mediated ERK activation with Smad pathway in TGF-beta1 induction of p21WAF1/Cip1.
    Kim YK; Bae GU; Kang JK; Park JW; Lee EK; Lee HY; Choi WS; Lee HW; Han JW
    Cell Signal; 2006 Feb; 18(2):236-43. PubMed ID: 15979845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arsenic trioxide induces apoptosis through JNK and ERK in human mesothelioma cells.
    Eguchi R; Fujimori Y; Takeda H; Tabata C; Ohta T; Kuribayashi K; Fukuoka K; Nakano T
    J Cell Physiol; 2011 Mar; 226(3):762-8. PubMed ID: 20799280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of p21WAF1 expression via Sp1-binding sites by tamoxifen in estrogen receptor-negative lung cancer cells.
    Lee TH; Chuang LY; Hung WC
    Oncogene; 2000 Aug; 19(33):3766-73. PubMed ID: 10949931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arsenic trioxide phosphorylates c-Fos to transactivate p21(WAF1/CIP1) expression.
    Liu ZM; Huang HS
    Toxicol Appl Pharmacol; 2008 Dec; 233(2):297-307. PubMed ID: 18822310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. UCN-01-induced cell cycle arrest requires the transcriptional induction of p21(waf1/cip1) by activation of mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase pathway.
    Facchinetti MM; De Siervi A; Toskos D; Senderowicz AM
    Cancer Res; 2004 May; 64(10):3629-37. PubMed ID: 15150122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Requirement for Ras/Raf/ERK pathway in naringin-induced G1-cell-cycle arrest via p21WAF1 expression.
    Kim DI; Lee SJ; Lee SB; Park K; Kim WJ; Moon SK
    Carcinogenesis; 2008 Sep; 29(9):1701-9. PubMed ID: 18296682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ras/ERK signaling pathway mediates activation of the p21WAF1 gene promoter in vascular smooth muscle cells by platelet-derived growth factor.
    Lee B; Moon SK
    Arch Biochem Biophys; 2005 Nov; 443(1-2):113-9. PubMed ID: 16248979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternative pathway of transcriptional induction of p21WAF1/Cip1 by cyclosporine A in p53-deficient human glioblastoma cells.
    Zupanska A; Adach A; Dziembowska M; Kaminska B
    Cell Signal; 2007 Jun; 19(6):1268-78. PubMed ID: 17321721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EGFR activation results in enhanced cyclooxygenase-2 expression through p38 mitogen-activated protein kinase-dependent activation of the Sp1/Sp3 transcription factors in human gliomas.
    Xu K; Shu HK
    Cancer Res; 2007 Jul; 67(13):6121-9. PubMed ID: 17616668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tamoxifen-induced activation of p21Waf1/Cip1 gene transcription is mediated by Early Growth Response-1 protein through the JNK and p38 MAP kinase/Elk-1 cascades in MDA-MB-361 breast carcinoma cells.
    Kim CG; Choi BH; Son SW; Yi SJ; Shin SY; Lee YH
    Cell Signal; 2007 Jun; 19(6):1290-300. PubMed ID: 17307334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibronectin stimulates human lung carcinoma cell proliferation by suppressing p21 gene expression via signals involving Erk and Rho kinase.
    Han S; Sidell N; Roman J
    Cancer Lett; 2005 Feb; 219(1):71-81. PubMed ID: 15694666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional activation of c-Fos by constitutively active Galpha(16)QL through a STAT1-dependent pathway.
    Lo RK; Wong YH
    Cell Signal; 2006 Dec; 18(12):2143-53. PubMed ID: 16781847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DDX3, a DEAD box RNA helicase with tumor growth-suppressive property and transcriptional regulation activity of the p21waf1/cip1 promoter, is a candidate tumor suppressor.
    Chao CH; Chen CM; Cheng PL; Shih JW; Tsou AP; Lee YH
    Cancer Res; 2006 Jul; 66(13):6579-88. PubMed ID: 16818630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells.
    Huang Y; Li X; Jiang J; Frank SJ
    Oncogene; 2006 Dec; 25(58):7565-76. PubMed ID: 16785991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.